s6y

FOXO TECHNOLOGIES INC.

Ticker
FOXO, FOXOW
CIK
1812360
Industry
Services-Commercial Physical & Biological Research
Formerly
Delwinds Insurance Acquisition Corp.

Financials 36

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q/A Quarterly Report for period ending Mar 31, 2025
  9. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2025
  10. 10-Q Quarterly Report for period ending Mar 31, 2025

All 36 financials filings

News 150

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 150 news filings

Ownership 93

  1. 3 Initial statement of beneficial ownership of securities
  2. SC 13G/A Major Shareholders
  3. SC 13D/A Major Shareholders
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. SC 13D Major Shareholders
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. SC 13D/A Major Shareholders

All 93 ownership filings

Prospectus 133

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  4. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 133 prospectus filings

Proxies 30

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. DEF 14C Definitive information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  5. DEF 14C Definitive information statements
  6. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  7. DEF 14C Definitive information statements
  8. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  9. DEF 14C Definitive information statements
  10. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

All 30 proxies filings

Other 98

  1. SCHEDULE 13G
  2. SCHEDULE 13D
  3. EFFECT Notice of Effectiveness
  4. SCHEDULE 13G
  5. D/A Exempt (Private) Offering
  6. D Exempt (Private) Offering
  7. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  8. D Exempt (Private) Offering
  9. EFFECT Notice of Effectiveness
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 98 other filings